US Stock MarketDetailed Quotes

DVA DaVita

Watchlist
  • 149.830
  • +0.460+0.31%
Close Mar 19 16:00 ET
  • 149.830
  • 0.0000.00%
Post 20:01 ET
11.99BMarket Cap13.96P/E (TTM)

About DaVita Company

DaVita, Inc. engages in the provision of medical care services. It operates through the following two segments: US Dialysis and Related Lab Services, and Other-Ancillary Services and Strategic Initiatives. The US Dialysis and Related Lab Services segment offers kidney dialysis services in the United States for patients suffering from chronic kidney failure. The Other-Ancillary Services and Strategic Initiatives segment consist primarily of pharmacy services, disease management services, vascular access services, clinical research programs, physician services, direct primary care, end stage renal disease seamless care organizations, and comprehensive care. The company was founded in 1994 and is headquartered in Denver, CO.

Company Profile

SymbolDVA
Company NameDaVita
Listing DateOct 30, 1995
Issue Price15.50
Founded1994
CEOMr. Javier J. Rodriguez
MarketNYSE
Employees76000
Fiscal Year Ends12-31
Address2000 16th Street
CityDenver
ProvinceColorado
CountryUnited States of America
Zip Code80202-7198
Phone1-720-631-2100

Company Executives

  • Name
  • Position
  • Salary
  • Javier J. Rodriguez
  • Director and Chief Executive Officer
  • 6.71M
  • Joel Ackerman
  • Chief Financial Officer and Treasurer
  • 6.87M
  • Michael David Staffieri
  • Chief Operating Officer Emeritus
  • 10.42M
  • James O. Hearty
  • Chief Compliance Officer
  • 2.73M
  • Kathleen Alyce Waters
  • Chief Legal and Public Affairs Officer
  • 5.61M
  • Christopher M. Berry
  • Chief Accounting Officer
  • --
  • David P. Maughan
  • Chief Operating Officer, DaVita Kidney Care
  • --
  • Pamela M. Arway
  • Chairman of the Board
  • 497.46K
  • Dennis W. Pullin
  • Director
  • --
  • Jason M. Hollar
  • Independent Director
  • 364.96K
  • Wendy L. Schoppert
  • Independent Director
  • 106.86K
  • Phyllis R. Yale
  • Independent Director
  • 374.96K
  • Barbara J. Desoer
  • Independent Director
  • 384.96K
  • Adam H. Schechter
  • Independent Director
  • 334.96K
  • Gregory J Moore
  • Independent Director
  • 355.89K
  • Charles G. Berg
  • Independent Director
  • 322.46K

Trending Stocks

Best Growth Stocks Best Growth Stocks

Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

Unlock Now
Discussing
Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context, Show More
Reassessing Chinese Assets
Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.